May 17-18
Big Data and the Evolution of Precision (Personalized) Medicine
George Poste, Ph.D., Chief Scientist, Complex Adaptive Systems, Professor, Health Innovation, Arizona State University
Next Steps in Cancer Immunotherapy
Eric H. Rubin, M.D., Vice President and Therapeutic Area Head, Oncology Early Development, Merck Research Laboratories
Clinical Biomarker Development: Well Begun Is Half Done
Xuemei Zhao, Ph.D., Principal Scientist, Translational Molecular Biomarkers, Merck
microRNAs as Biomarkers of Pancreatic Cancer
Subrata Sen, Ph.D., Professor and Deputy Chair, Translational Molecular Pathology, University of Texas MD Anderson Cancer Center
Circulating microRNAs as Progression Biomarkers for Parkinson's Disease
Sok Kean Khoo, Ph.D., Distinguished Associate Professor, Molecular Genomics, Cell & Molecular Biology, Grand Valley State University Michigan
miRNA as a Biomarker for Multiple Sclerosis
Roopali Gandhi, Ph.D., Assistant Professor, Neurology, Head of MS Biomarkers, Brigham and Women's Hospital, Harvard Medical School
Sifting Treasure from Trash: Mining for Extracellular RNA Markers of Cardiac Remodeling
Saumya Das, M.D., Ph.D., Assistant Professor, Medicine, Harvard Medical School
Prognostic Relevance and Genetic Profile of Circulating Tumor Cells and Circulating Tumor DNA in the Late Stage of Small Cell Lung Cancer Patients
Huifeng Niu, Ph.D., Director, Translational Medicine, Takeda Pharmaceuticals
Novel Methods for Enrichment of Mutations and Differentially Methylated Sequences from Liquid Biopsy Genomes
G. Mike Makrigiorgos, Ph.D., Professor, Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Ultrasensitive Measurement of Circulating Tumor DNA to Track Treatment Response and Failure
Abhijit A. Patel, M.D., Ph.D., Assistant Professor, Therapeutic Radiology, Yale University School of Medicine
cfDNA and Circulating Biomarkers in Brain Cancers
Matthias Holdhoff, M.D., Ph.D., Assistant Professor, Oncology, Johns Hopkins University School of Medicine
Rare Mutation Enrichment Using Molecular Competition Probes and Primers
David Yu Zhang, Ph.D., Assistant Professor, Bioengineering, Rice University
Circulating Tumor DNA: Applications and Challenges
Dr. Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics
